Veterinary Medicines

Prazpronto 20mg Spot-on solution for small Cats and Kittens

Not authorised
  • Praziquantel
Download as PDF

Product identification

Medicine name:
Prazpronto 20mg Spot-on solution for small Cats and Kittens
Prazpronto 20 mg spot-on oplossing voor katten en kittens
Active substance:
  • Praziquantel
Target species:
  • Cat
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
  • Praziquantel
    20.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Spot-on use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Netherlands
Package description:
  • A white pipette composed of a heat-formed shell composed of polypropylene/cyclic olefin copolymer/ethylene vinyl alcohol/polypropylene layer. Carton containing 1 pipette in individual foil sachets.
  • A white pipette composed of a heat-formed shell composed of polypropylene/cyclic olefin copolymer/ethylene vinyl alcohol/polypropylene layer. Carton containing 2 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell composed of polypropylene/cyclic olefin copolymer/ethylene vinyl alcohol/polypropylene layer. Carton containing 3 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell composed of polypropylene/cyclic olefin copolymer/ethylene vinyl alcohol/polypropylene layer. Carton containing 4 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell composed of polypropylene/cyclic olefin copolymer/ethylene vinyl alcohol/polypropylene layer. Carton containing 6 pipettes in individual foil sachets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 124169
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0633/001

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 26/01/2022
Download

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."